Book Value per Share: ADMA Biologics (ADMA)

Graphic logo of ADMA Biologics (ADMA)

The market trend for ADMA Biologics (ADMA), whose metric reaches 1.83, serves as an indicator of the business efficiency in producing immunoglobulins. ADMA Biologics (ADMA) is developing its own plasma collection centers to increase profits while simultaneously optimizing supply chains by expanding its list of contractors. This activity possesses defensive qualities, as demand for critical therapy remains stable and independent of economic crises or seasonal fluctuations.

ADMA Biologics Inc (ADMA): Share Book Value from 07/04/2022 to 10/27/2026
Manufactured products of ADMA Biologics, Inc.

To minimize risks when selecting an asset, one must evaluate its intrinsic value. This indicator is calculated as the difference between total assets and liabilities, divided by the number of shares. Analyzing the actual book value per share allows for the determination of the issuer's real capital. For ADMA Biologics (ADMA), growth in this value confirms the efficiency of owning plasma collection centers. Resource capitalization through patents ensures a steady strengthening of the company's financial foundation.

Competitors of ADMA Biologics (ADMA)

ARGX: Net Assets per Single Share|BNTX - Accounting Value per Share|ABVX: Book Value per Share|PTGX (protagonist-inc.com) - Book Value per Share|Net Assets per Single Share Immunovant IMVT|Share Book Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Book Value per Share|Accounting Value of a Share Adaptive Biotechnologies Inc. (ADPT)|Book Value per Share CLDX (Celldex Therapeutics)|auriniapharma.com - Book Value per Share|Net Assets per Single Share BioCryst Pharmaceuticals (BCRX)|VERA: Accounting Value of a Share|DNTH (Dianthus Pharma) - Net Assets per Single Share|Pharvaris Pharma (PHVS) - Accounting Value per Share|ABCL (AbCellera Biologics Inc) - Book Value per Share|Book Value per Share tourmalinebio.com (TRML)|Precigen (PGEN) - Accounting Value per Share|Accounting Value of a Share Pharming Group NV (PHAR)|Book Value per Share NKTR|Upstream Pharma - Net Assets per Share|ZBIO: Net Assets per Single Share|IMNM: Accounting Value per Share|GOSS (Gossamer Bio) - Net Assets per Single Share|Accounting Value per Share KalVista Pharma|SEPN (Septerna Corp) - Accounting Value per Share|Book Value per Share PVLA|Net Assets per Single Share Savara Inc. SVRA|Equity per Share rigel.com (RIGL)|ANAB: Book Value per Share|Net Asset Value per Share Astria Therapeutics Inc ATXS|enGene Bio - Book Value per Share|RAPT - Book Value per Share|Book Value per Share aerovatetx.com|ACRS (aclaristx.com) - Equity per Share|Net Assets per Single Share KYTX|Accounting Value per Share Tiziana Life Sciences Ltd.|Book Value per Share CABA|Book Value per Share Ventyx Biosciences, Inc VTYX|Accounting Value per Share Theratechnologies Inc.|Accounting Value of a Share avalotx.com AVTX|ELDN - Book Value per Share|AGEN - Net Assets per Single Share|Climb Bio, Inc. - Book Value per Share|ZURA (Zura Bio Ltd) - Net Assets per Share|Net Assets per Single Share ATYR (aTyr Pharma, Inc.)|Net Asset Value per Share ADAG|Net Assets per Single Share ImageneBio Inc (IMA)|Net Assets per Single Share STTK (shattucklabs.com)|EQ: Net Assets per Single Share|Net Asset Value per Share Connect Biopharma Holdings CNTB|Book Value per Share IMUX|ATRA - Book Value of One Share|inflarx.de - Book Value per Share|X4 Pharmaceuticals Inc. (XFOR) - Net Assets per Share|Book Value per Share ACET|Accounting Value per Share CELU|INMB (INmune Bio, Inc.) - Net Assets per Single Share|Net Assets per Share barinthusbio.com (BRNS)|Book Value per Share KZR (Kezar Life Sciences, Inc.)|Book Value per Share SAB Biotherapeutics Inc. SABS|Akari Therapeutics plc (AKTX) - Book Value per Share|ENLV: Equity per Share|QTTB (q32bio.com) - Net Assets per Single Share|geovax.com (GOVX) - Accounting Value per Share|EDSA (Edesa Biotech) - Book Value per Share|Book Value per Share IBIO|CARM - Net Assets per Single Share|Share Book Value XTL Bio (XTLB)|Book Value per Share Bolt Biotherapeutics, Inc.|Accounting Value of a Share HCW Biologics, Inc. HCWB|Aptevo - Book Value per Share|AIM: Book Value per Share|Net Assets per Single Share aditxt.com ADTX|GRI (GRI Bio Corporation) - Accounting Value of a Share|Net Assets per Single Share XRTX|Accounting Value per Share reshapelifesciences.com|Book Value per Share REVB|Book Value per Share Indaptus Therapeutics Inc INDP|Accounting Value per Share Scinai|Accounting Value of a Share CalciMedica Inc CALI|Book Value per Share AFMD (Affimed Therapeutics)|ALLK: Net Assets per Share|HOOK (hookipapharma.com) - Net Assets per Single Share|IGMS (IGM Biosciences) - Accounting Value per Share|Net Assets per Single Share ITOS|Accounting Value per Share Ocean Biomedical Corp (OCEA)|Accounting Value per Share TCBP|Book Value per Share THRD (thirdharmonicbio.com)